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Background: The nucleases hSNM1A and hSNM1B are implicated in DNA interstrand cross-link repair.
Results: hSNM1A and hSNM1B were biochemically characterized using undamaged and cross-linked DNA. A real-time assay
for the nucleases suitable for inhibitor identification was developed.
Conclusion: Preferential hSNM1A activation by high molecular weight and cross-linked DNA was observed.
Significance: This work provides a basis for hSNM1A inhibitor development for improved cancer therapy.
Human SNM1A and SNM1B/Apollo have both been impli-
cated in the repair of DNA interstrand cross-links (ICLs) by
cellular studies, and SNM1B is also required for telomere pro-
tection.Here, we describe studies on the biochemical character-
ization of the SNM1A and SNM1B proteins. The results reveal
some fundamental differences in the mechanisms of the two
proteins. Both SNM1A and SNM1B digest double-stranded and
single-stranded DNAwith a 5-to-3 directionality in a reaction
that is stimulated by divalent cations, and both nucleases are
inhibited by the zinc chelator o-phenanthroline. We find that
SNM1A has greater affinity for single-stranded DNA over dou-
ble-stranded DNA that is not observed with SNM1B. Although
both proteins demonstrate a low level of processivity on low
molecular weight DNA oligonucleotide substrates, when pre-
sented with high molecular weight DNA, SNM1A alone is ren-
dered much more active, being capable of digesting kilobase-
long stretches of DNA. Both proteins can digest past ICLs
induced by the non-distortingminor groove cross-linking agent
SJG-136, albeit with SNM1A showing a greater capacity to
achieve this. This is consistent with the proposal that SNM1A
and SNM1B might exhibit some redundancy in ICL repair.
Together, our work establishes differences in the substrate
selectivities of SNM1A and SNM1B that are likely to be relevant
to their in vivo roles and which might be exploited in the devel-
opment of selective inhibitors.
Interstrand cross-links (ICLs)3 are an extremely cytotoxic
form of DNA damage that covalently tethers the two strands of
the double helix and which inhibits fundamental nuclear func-
tions, including transcription and DNA replication (1–3).
Accumulating evidence implicates spontaneously arising cellu-
lar ICLs, induced by metabolic intermediates and oxidized lip-
ids, as a formidable threat to genomic integrity (4). Indeed, the
inability to repair these ICLsmight directly contribute to devel-
opmental defects and tumor formation, as exemplified in the
inherited disorder Fanconi anemia (FA) (5, 6), where ICL repair
is compromised (7). In addition, a variety of clinically important
alkylating anticancer drugs induces cell death through ICL for-
mation, and response to therapy has been directly linked to ICL
repair capacity (8). It is, therefore, critical to gain an improved
understanding of ICL repair from both cancer treatment and
prevention viewpoints.
Inmammalian cells ICLs are primarily detected during DNA
replication, where fork stalling elicits the repair response, and
proteins within the FA pathway coordinate several key stages
during ICL repair (1, 7, 9–12). A number of recent studies
implicate the XPF-ERCC1 nuclease in the initial incision of the
ICLs, and the localization and targeting of this factor to ICL-
damaged chromatin is dependent upon the Slx4/FANCP factor
(10, 12–14). The incised ICL intermediates are then subject to
further processing allowing fork restart through the combined
actions of translesion synthesis polymerases and homologous
recombination factors (15–17). Evidence suggests that a key
step during processing of incised ICLs involves the trimming or
degradation of the tethered oligonucleotide remaining after
ICL incision. Indeed, this step has been directly visualized in a
Xenopus in vitro ICL repair system that employs replication-
competent cell extracts (17). We have recently shown that the
hSNM1A exonucleasemight play an important role during this
trimming step, as this protein acts in concert with XPF-ERCC1
to initiate ICL repair in vivo and displays biochemical activities
consistent with such a role in vitro (14).
Purified hSNM1A is able to digest DNA-bearing site-specific
ICLs produced by the non-distorting minor groove binding
agent SJG-136 past the site of the lesion, leaving a single nucle-
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otide covalently attached to the opposing strand (14) (illus-
trated schematically in Fig. 1A). These tethered mononucle-
otides are established as good substrates for translesion
synthesis polymerases to copy past (18–20), suggesting that
hSNM1A facilitates ICL repair by providing a substrate for the
later stages of ICL repair. hSNM1A is a member of the -CASP
structural family of metallo--lactamase (MBL)-fold-contain-
ing proteins that includes antibiotic resistance genes and pro-
teins involved in nucleic acid processing. In Saccharomyces
cerevisiae a single, possibly foundermember of this family, Pso2
(formerly known as Snm1), is present and is critical for normal
ICL resistance (21, 22). Vertebrates possess three orthologs of
Pso2, hSNM1A, hSNM1B/Apollo, and hSNM1C/Artemis. Bio-
chemically, the three human proteins have been shown to
exhibit either 5-3 exonuclease (hSNM1A and hSNM1B) (14,
23–27) or structure-specific endonuclease (hSNM1C) (28, 29)
activities; although Artemis was initially thought to have a con-
stitutive exonuclease activity, this has more recently been
shown to be due to a contaminating co-purified exonuclease
(30). hSNM1B (also known as Apollo) has recently been sug-
gested to play a role in DNA repair, possibly in both ICL repair
within the FA pathway and in the ATM-mediated response to
ionizing radiation-induced double-strand breaks (31, 32). Fur-
thermore, hSNM1B was identified as a TRF2-interacting pro-
tein and, therefore, plays a role in telomere maintenance in
association with the Shelterin complex, protecting leading
strand telomeres and preventing non-homologous end-join-
ing-mediated chromosome fusions (25–27, 33–35). Because
disruption of non-homologous end-joining factors rescues the
embryonic lethality in hSNM1B-disrupted mice, this suggests
that the dysfunctional telomeres and other abnormal chromo-
somal structures that accumulate in hSNM1B-deficient cells
prevent the development of viable mammals (36). Indeed, a
splice variant in hSNM1B that leads to production of a form of
hSNM1B that is unable to interact with TRF2 leads to a form of
Hoyeraal-Hreidarsson syndrome where patients exhibit pre-
mature aging, bone marrow failure, and immunodeficiency
(37).
Despite their importance in maintaining human genomic
integrity, no detailed biochemical analysis of the human
SNM1A and SNM1B factors has been carried out. Here we
present a detailed characterization of the enzymatic properties of
hSNM1A and hSNM1B/Apollo, identifying metal ion require-
ments, substrate preferences, and a striking, differential capacity
for processing highmolecular weight and damaged DNA.
EXPERIMENTAL PROCEDURES
Purification of hSNM1A and hSNM1B—N-terminal-trun-
cated hSNM1A (hSNM1A-(608–1040)) was purified as in a
previous study (14). Briefly, hSNM1A-(608–1040) was purified
from 24 liters of bacterial culture using expression from the
pNH-TrxT plasmid containing an N-terminal His6 and thiore-
doxin TEV protease cleavable tag (accession number
GU269914, (38)). After cell lysis (50mMHEPES, pH7.5, 150mM
NaCl, 5% glycerol, 0.5mMTCEP, supplementedwith a protease
inhibitor mixture (Roche Applied Science) using a Emulsi-
flex-C5 cell breaker (Avestin) followed by sonication (2  15
min, 15 s on/15 s off) and centrifugation (38,000 g, 1 h)), the
lysate was separated using phosphocellulose P11 resin (What-
man), loaded at 150 mM NaCl, and eluted with 20 mM HEPES,
pH 7.5, 600 mM NaCl, 0.5 mM TCEP, 10% glycerol. The eluate
was further purified on a His-Trap column (50 mMHEPES, pH
7.5, 300 mM NaCl, 10 mM imidazole, 0.5 mM TCEP, elution
gradient 10–300 mM imidazole) and in a S75 gel filtration step
(10 mM HEPES, pH 7.5, 300 mM NaCl, 0.5 mM TCEP, 5% glyc-
erol). After removal of the tag with tobacco etch virus protease
(1:20 ratio) at 4 °C overnight, the protein was rebound to a
His-Trap column and eluted as above to remove cleaved tag
followed by further purification using a heparin column (20mM
HEPES, pH 7.5, 150 mM NaCl, 0.5 mM TCEP, 5% glycerol, elu-
tion gradient 150 mM-2 M NaCl) and an SP column (20 mM
HEPES, pH 7.5, 50mMNaCl, 0.5mMTCEP, 5% glycerol, elution
gradient 50mM2MNaCl). At each stage the presence of protein
was confirmed on an InstantBlue-stained SDS-PAGE gel, and
the identity of the final preparation was confirmed using elec-
trospray ionization-TOFmass spectrometry or by tandemmass
spectrometry of tryptic peptides.
A truncated hSNM1B-(6–328) protein was purified from
recombinant Escherichia coli. The protein was cloned into the
expression vector pNIC-Zb, which uses a combination of a
His10 sequence and the Z-basic tag (GenBankTM accession
number GU452710) to promote solubility and efficient purifi-
cation. The plasmid was introduced into BL21(DE3)-R3-
pRARE2, the cells were grown in Terrific Broth (TB) medium
containing kanamycin, and expression was induced with iso-
propyl 1-thio--D-galactopyranoside. The proteins were
extracted by sonication in binding buffer (20 mM HEPES, pH
8.0, 1 M NaCl, 5% glycerol, 10 mM imidazole, 1 mM TCEP) and
loaded on a 5-mlHisTrap column at 4ml/min. The columnwas
washed with 20 volumes of wash buffer (20 mMHEPES, pH 8.0,
250mMNaCl, 5% glycerol, 30mM imidazole, 0.5mMTCEP) and
eluted with Elution buffer (20 mM HEPES, pH 8.0, 250 mM
NaCl, 5% glycerol, 300 mM imidazole, 0.5 mM TCEP). The
eluted fraction was further purified by size exclusion chro-
matography on a Superdex S75 HR 16/60 column in a buffer
containing 20 mM HEPES, pH 8.0, 150 mM NaCl, 20 mM
glycine, 5% glycerol, 20 M ZnCl2, 1 mM TCEP, at 1.2
ml/min. An inactive mutant version of hSNM1B-(6–328,
D35A/H36A) in the vector pNIC-Zb was expressed and puri-
fied using an identical procedure. Antibodies used to confirm
the identity of proteins were the anti-hSNM1A antibody from
Abcam, Cambridge, UK (goat-polyclonal, catalogue number
ab14805, used at 1:1000 dilution) and the anti-hSNM1B from
Abgent Europe, Oxford, UK (rabbit-polyclonal, catalogue num-
ber ap5426c, used at 1:500 dilution).
Substrate Preparation—The substrates were constructed as
shown in supplemental Table S1 using the sequences listed in
supplemental Table S2. All oligonucleotides, including the
fluorescein- and/or BHQ1-containing substrates were synthe-
sized by Eurofins MWG Operon (Ebersberg, Germany). To
make double-stranded DNA (dsDNA), RNA/DNA hybrids, or
double-stranded RNA (dsRNA) and to ensure hairpin sub-
strates were folded back, complementary strands were
annealed by heating to 100 °C for 5 min followed by stepwise
cooling to room temperature (20 °C). Themethodology used to
prepare and purify DNA oligonucleotide duplexes containing a
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single site-directed ICL has recently been published in detail
(14, 39). If required, single-stranded DNA substrates were
labeled at the 3-end with [-32P]dATP (1 l; 0.37 MBq) and
terminal deoxynucleotidyltransferase (20 units; Fermentas),
and dsDNA substrates, after annealing where necessary, were
labeled with [-32P]dATP and Klenow fragment lacking 3-ex-
onuclease activity (5 units; New England Biolabs).
Nuclease Assays—Standard exonuclease assays were carried
out in 10-l reactions containing 20 mM HEPES-KOH, pH 7.5,
50 mM KCl, 0.5 mM DTT, 10 mM MgCl2, 0.05% Triton-X, 0.1
mg/ml BSA, 5% glycerol, and the indicated amounts of enzyme.
The reactionswere started by the addition of substrate (amount
indicated) and incubated at 37 °C for 30 min followed by the
addition of 2l of stopmixture (95% formamide, 10mMEDTA,
0.25% xylene cyanol, 0.25% bromphenol blue) and heating to
95 °C for 3 min. The samples were analyzed using denaturing
20% polyacrylamide gels containing 0.5 Tris borate EDTA
buffer and 7 M urea. Gels were run at 525 V for 1.5 h. With
radioactive substrate, gels were dried and exposed to a Kodak
phosphorimaging screen and scanned using a Typhoon 9400
instrument (GE Healthcare); with fluorescently labeled sub-
strates, gels were imaged using the fluorescence mode of the
Typhoon 9400 instrument, with blue laser (488 nm) excitation
and an emission filter set to 520 nm band-pass 40 (detecting
light between 500–540 nm).
Metal ion dependence experimentswere carried out in buffer
containing 0.01, 0.1, 1, 5, or 10 mM MgCl2, MnCl2, ZnCl2, or
CaCl2 instead of the 10 mM MgCl2 of the standard reactions,
keeping ionic strength constant by varying potassium chloride
concentration. The substrate concentration chosen for com-
paring metal ion dependence of the two enzymes was 1000 nM,
which exceeds the Km (10-fold) for the hSNM1A-catalyzed
hydrolysis (see Fig. 3A). It is worth noting that at this substrate
concentration the hSNM1B-catalyzed hydrolysis of dsDNA is
not maximal, but an equivalent level of substrate was used for
comparison purposes after a normalization experiment was
carried out to determine the amounts of hSNM1A and
hSNM1B thatwould result in an approximately equivalent level
of hydrolysis (supplemental Fig. S2A). The chelator experi-
ments were carried out as in the standard assay but supple-
mentedwith 0.1, 1, 5, 10, or 25mM o-phenanthroline, EGTA, or
EDTA.
Oligonucleotide competition experiments were carried out
in 10-l reactions as for the standard assay, with three reactions
started concurrently by the addition of dsDNA or single-
stranded DNA (ssDNA) substrate (1000 nM). Reaction 1 was
stopped after 5min by the addition of stopmixture and boiling,
reaction 2was supplementedwith an excess (16.67M) of unla-
beled substrate and subsequently stopped at 60 min, and reac-
tion 3 was stopped at 60 min, with all samples analyzed as
described above.
Plasmid digestion experiments were carried out in two
stages. First, plasmid (325 ng, supplemental Fig. S7C) was either
left untreated, gapped (nicked at five sites within a 52 base pair
region) with Nb.BbvCI (5 units; New England Biolabs), or lin-
earized with HindIII (10 units; New England Biolabs) in 10 l
for 90 min at 37 °C in 1New England Biolabs reaction buffer
2. Second, reaction buffer (final composition 20 mM HEPES-
KOH, pH 7.5, 50 mM KCl, 0.5 mM DTT, 10 mM MgCl2, 0.05%
Triton X, 0.1 mg/ml BSA, 5% glycerol) and, in competition
experiments unlabeled 21-mer dsDNA, were added and
hSNM1A or hSNM1B were allowed to digest the plasmid for
1 h. Products were analyzed on 1% agarose gels containing 1
Tris borate EDTA (130 V, 150 min).
Kinetic Characterization of hSNM1A and hSNM1B—Reac-
tions were carried out with varying concentrations of substrate
and enzyme in the reaction buffer as described above. Reac-
tions, prewarmed to 37 °C, were initiated by the addition of
radiolabeled substrate, sampled at 4 appropriate time intervals,
and quenched with stop mixture. The amount of product was
determined after gels were dried and scanned by quantification
using the ImageQuant (GE Healthcare) software package. The
gels were quantified, and the products were analyzed assuming
that the product of length n  1 (where substrate is n nucleo-
tides long) is the result of one hydrolysis reaction cycle, the
product of length n  2 is the result of two hydrolysis cycles,
and the product of lengthnm is the result ofmhydrolysis (40,
41). The substrate concentrations were chosen to range from
Km/8 to 8-fold Km where possible, and the enzyme concentra-
tionswere adjusted appropriately tomeasure a linear part of the
initial reaction rate. The final substrate concentrations ranged
from 10 to 1,200 and from 1.25 to 1,200 nM to analyze hSNM1A
hydrolysis of ds- and ssDNA, respectively, and from 10–12,000
nM and from 1.25–18,000 nM to analyze hSNM1B hydrolysis of
ds and ssDNA. Enzyme concentrations ranged from 0.5 to 4.1
nM (hSNM1A on dsDNA and ssDNA), 6 to 88 nM (hSNM1B on
dsDNA), and 6 to 131 nM (hSNM1B on ssDNA). Initial rates of
reaction at the range of substrate concentrations, normalized to
enzyme concentration, were determined, and kinetic parame-
ters were determined by nonlinear regression fitting of the data







Curve-fittingwas performedusingKaleidagraph software (Syn-
ergy Software).
Real-time Measurements—All measurements were carried
out in 96-well plates using a SpectraMaxM2e fluorescent plate
reader (Molecular Devices) in fluorescence top read mode
using SoftMaxPro software (Molecular Devices) to control the
settings. Emission spectra weremeasuredwith 6 readings taken
from 500 to 600 nm (2 nm steps) with excitation set to 495 nm
and cutoff at 515 nm. Time courses were measured, with 6
readings taken at 7-s intervals for 12min, with excitation at 495
nm, emission at 525 nm, and cutoff set to 515 nm.
pH Rate Profile of kcat for the hSNM1A WT and H994A
Reactions—Reactions were carried out with 1000 nM dsDNA
substrate when hydrolysis of dsDNA by hSNM1AWT reached
saturation (see Fig. 3A) and when initial rate could be reason-
ably assumed to be an estimate of the kcat of the reaction. Reac-
tions, prewarmed to 37 °C, were initiated by the addition of
radiolabeled substrate, sampled at four appropriate time inter-
vals to measure initial reaction rate, and quenched with stop
mixture followed by determination of amount of product as
described above for kinetic characterization. The experiments
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were carried out as described for the standard nuclease assays
but used HEPES buffer (pH 7.0–8.8) or potassium glycinate
(pH 8.6–11.0) to maintain constant pH. The real-time mea-
surements were carried out as described above, with the initial
rate determined during the linear part of the reaction and
quoted as fluorescence units/nM enzyme/min.
Due to the bell-shaped curve obtained, the pHdependence of
kcat was fitted to a model whereby the enzyme-substrate com-
plex is subject to two possible ionizations but is active in the




10pKa110pKa2 	 102pH  10pKa110pH
(Eq. 2)
where kcat(max) is the maximal turnover number of the enzyme,
and Ka1 and Ka2 are the acid dissociation constants of the
enzyme-substrate complex. Curve fitting was carried out using
logged data in Kaleidagraph software (Synergy Software).
RESULTS
hSNM1A and hSNM1B Purification—hSNM1A was over-
produced and purified from E. coli as an N-terminal-truncated
form containing all hSNM1 conserved regions (hSNM1A-
(608–1040)) as described elsewhere (14). The protein, purified
close to homogeneity, is shown on an InstantBlue-stained
gel, and its identity was confirmed by an immunoblot probed
with anti-hSNM1A antibody (supplemental Fig. S1, A–B) as
well as by electrospray ionization-TOF mass spectrometry
(data not shown). hSNM1B was also purified from E. coli
using a C-terminal-truncated construct (hSNM1B-(6–328))
containing all conserved domains (shown in Fig. 1B), and the
purified proteins are shown on an InstantBlue-stained gel in
supplemental Fig. S1C, with their identity confirmed by
immunoblot with anti-hSNM1B antibodies (supplemental
Fig. S1D) as well as by mass spectrometry (data not shown).
The relative domain architecture of the human members of
the Snm1 family of proteins is shown compared with the
related yeast interstrand cross-link repair protein Pso2 in
Fig. 1B.
hSNM1A and hSNM1B Are 5-to-3 Exonucleases That
Require Divalent Metal Cations and Are Inhibited by Metal
Chelation—Previously published data suggested that hSNM1A
requires the presence of magnesium divalent ions as a cofactor
and is inhibited in the presence of zinc and iron(III) (23, 24),
whereas the 5-exonuclease activity of hSNM1B was studied
only in the presence of magnesium (25, 26). Here, we initially
assessed the protein activity in the presence of a broad range of
concentrations of several divalent cations over a 30-min time
course.
Both enzymes catalyzed the hydrolysis of dsDNA in the
5-to-3 direction in the presence of magnesium (Fig. 1, D and
E, lanes 1–5) or manganese ions (Fig. 1,D and E, lanes 6–10) in
a dose-dependent manner, with the reaction rate being signifi-
cantly higher in the presence of manganese for hSNM1B, but
not for hSNM1A,where the reaction rate throughout the tested
manganese concentration range (0.01–10 mM) was approxi-
mately equivalent to that observed in the presence of 1 mM
magnesium. This pattern has been consistently reproduced
with multiple enzyme preparations obtained using a variety of
procedures (data not shown), so is unlikely, at least solely, to be
a function of metal ions co-purified with the enzyme. The
hSNM1A and hSNM1B reaction is stimulated to a lesser extent
by calcium (Fig. 1, D and E, lanes 16–20) and for hSNM1B
occurs in the presence of a low concentration of zinc (0.01 mM)
(Fig. 1E, lane 11) while being apparently inhibited at concentra-
tions of zinc above 0.1 mM (Fig. 1E, lanes 12–15). For hSNM1B,
we therefore explored the effect of varying zinc concentrations
in the presence and absence of a fixed concentration of magne-
sium (Fig. 1H). This revealed that in the presence of magne-
sium, increasing zinc concentrations above 0.002 mM is stimu-
latory but becomes inhibitory above 0.1 mM zinc, as confirmed
by the reactions performed in the absence of magnesium. For
hSNM1A (Fig. 1D, lane 11, as compared with lanes 12–15),
activity was not apparent even at low zinc concentrations as
confirmed by titrating zinc in the absence of magnesium ions
(data not shown).We saw no significant activity in the presence
of a variety of concentrations of CoCl2 or NiCl2, although these
experiments are complicated by the fact that the cofactors pre-
cipitate quickly due to their reduction in the dithiothreitol con-
taining reaction buffer (data not shown). Finally, by substitut-
ing, on the basis of a homology model (42, 43), two predicted
active site residues, D736A/H737A in hSNM1A and D35A/
H36A in hSNM1B as indicated in Fig. 1C, we showed that the
nuclease activity of the protein is intrinsic to the protein rather
than due to contaminating exonucleases because substitution
of these residues hindered catalysis (supplemental Fig. 2,A and
B). Some residual nuclease activity was apparent with the dou-
ble-mutated hSNM1A protein in the presence of manganese
ions (supplemental Fig. S2A, lanes 6–10), which might be due
to the tighter binding of manganese in the active site as com-
pared with magnesium that could lead to retention of manga-
nese cofactor in the active site even in the absence of the
D736A/H737A residues (44, 45).
Because the identity of the physiological active site metal ion
is still unclear, we addressed this issue by carrying out the reac-
tion in the presence of a variety of metal ion chelating com-
pounds. We used o-phenanthroline, which is relatively specific
toward zinc (46, 47), EDTA, a general metal chelator, and
EGTA,whichhas a higher affinity for calciumas comparedwith
magnesium (48, 49). The activity of both hSNM1A and
hSNM1B was effectively inhibited in the presence of the zinc
chelator o-phenanthroline (Fig. 1, F and G, lanes 1–6), with a
lower concentration required to inhibit hSNM1B (compare
lanes 3 in Fig. 1, F andG). EGTA was not strongly inhibitory to
the hSNM1A reaction, stimulating it at low concentrations up
to 5 mM and still showing activity similar to that in the absence
of chelator at 25 mM EGTA (Fig. 1F, lanes 7–12). In contrast,
hSNM1B activity was inhibited at EGTA concentrations of 5
mM and higher, with some residual activity at 25 mM EGTA
(Fig. 1G, lanes 7–12). EDTA, a nonspecificmetal chelator, stim-
ulated hSNM1A at low concentrations where it did not affect
hSNM1Bactivity significantly (0.01–1mM, Fig. 1,F andG, lanes
14 and 15). At higher concentrations (5–25 mM), EDTA was
inhibitory to both hSNM1A and hSNM1B to a greater extent
than EGTA but to a lesser extent than o-phenanthroline (Fig.
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1, F and G, lane 16–18). We conclude that divalent cations
are important for hSNM1A and hSNM1B catalysis, and due
to the efficient inhibition conferred by o-phenanthroline,
zinc is a very attractive candidate reaction co-factor, espe-
cially given its role in bacterial metallo--lactamase cataly-
sis. However, further work is required before unequivocal
assignment of the metal cofactor requirements of the SNM1
proteins.
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hSNM1A and hSNM1B Digest DNA with a Similar Catalytic
Efficiency but Show Distinct Substrate Binding Properties—
hSNM1A and hSNM1B have previously been shown to be able
to digest both dsDNA and ssDNA (14, 23–26). To investigate
the relative efficiency of these reactions, we first ascertained
whether or not the hSNM1A and hSNM1B reactions are pro-
cessive; for a non-processive enzyme, the assumption can be
made that each nucleotide removal is the result of an indepen-
dent hydrolysis event. Unlike an endonuclease activity, which
usually occurs at a single incision point, during an exonuclease
reaction the substrate may be released and rebound by the
enzyme between hydrolysis of subsequent nucleotides (non-
processive), or further hydrolysis of the product may occur
without product release (processive). We investigated the pro-
cessivity of both hSNM1A and hSNM1B by adding an excess of
unlabeled substrate to the reaction after a measured time delay
and stopping the reaction after a fixed time period (Fig. 2). The
amount of hSNM1A and hSNM1B used was such that the reac-
tion progress in a 30-min time period was approximately simi-
lar, as defined by experiments normalizing for activity shown in
supplemental Fig. S3. The results suggest that hSNM1A hydro-
lysis of both dsDNA (Fig. 2A, lanes 1–3) and ssDNA (Fig. 2A,
lanes 4–6) is not strongly processive, because the addition of
excess unlabeled DNA (lanes 2 and 5) has the same effect as
stopping the reaction with stop buffer (lanes 1 and 4) as quan-
tified in Fig. 2B. The hSNM1B reaction may be slightly more
processive in character as hydrolysis of dsDNA (Fig. 2A, lanes
7–9) and ssDNA (Fig. 2A, lanes 10–12), quantified in Fig. 2C, is
less sensitive to the addition of excess competitor (lanes 8 and
11 compared with lanes 7 and 10, respectively). The greater
processivity of hSNM1B compared with hSNM1A could be
related to the lower substrate binding efficiency of hSNM1B, as
discussed below. Nevertheless, overall processivity of hSNM1B
was low and likely does not invalidate the assumptions used in
analyzing our data.
We were then able to measure the initial rate of reaction on
both ssDNA and dsDNA substrates, normalized against
enzyme concentration, at varying substrate concentrations
such that the Michaelis-Menten plots in Fig. 3 could be con-
structed and the kinetic parameters kcat and Km obtained
through non-linear regression fitting of the data. The kinetic
parameters, tabulated as an inset of Fig. 3, suggest that
hSNM1A and hSNM1B digest dsDNA with comparable cata-
lytic efficiency (kcat 
 25 min1), although substrate binding,
reflected in the Km value, appeared to be stronger for the
hSNM1A/dsDNA interaction (Fig. 3A) as compared with the
hSNM1B/dsDNA interaction (Fig. 3C). When hydrolysis of
ssDNA was assessed, the catalytic efficiency of the hSNM1A
reaction was comparable with dsDNA hydrolysis (14 min1
compared with 26 min1), but ssDNA appeared to be bound
more tightly, with saturation reached at low nanomolar sub-
strate concentrations (Fig. 3B). This observation explains why
hSNM1A was previously shown to hydrolyze ssDNA with
greater efficiency than dsDNA (14, 23) because in these studies
substrate concentration (100 nM)was at subsaturation levels for
dsDNA hydrolysis and in excess of saturation for ssDNA
hydrolysis. Finally, when ssDNA hydrolysis by hSNM1B was
investigated, it was impossible to reach saturation even at the
highest concentration of substrate used (18 M) (Fig. 3D), and
although the turnover rate appeared relatively high (in excess of
55 min1), it is unlikely to be reached at physiological DNA
concentrations.
Another human 5-3 exonuclease, human exonuclease 1,
has been shown to have a high preference for a nicked substrate
compared with blunt-ended DNA (50). To ensure that the dif-
ference in substrate binding by hSNM1B and hSNM1Awas not
simply due to substrate preference, wemeasured the initial rate
of hydrolysis by hSNM1A and hSNM1B using blunt-ended,
recessed, and nicked dsDNA, constructed from the oligonu-
cleotides shown in supplemental Table S1 (sequences listed in
supplemental Table S2) and saw no significant preference for
recessed or nicked dsDNA by either enzyme as shown qualita-
tively in supplemental Fig. S4,A–D and as quantified in supple-
mental Fig. S4E.
hSNM1A and hSNM1B Preferentially Hydrolyze DNA Over
RNA Substrates—It has been previously shown that hSNM1A
protein hydrolyzes RNA as well as DNA substrates (24). This
resultwas confirmedhere butwith a strong preference forDNA
shown (supplemental Fig. S5A). We found that hSNM1B can
also hydrolyze both RNAandDNAand has a similar preference
for DNA (supplemental Fig. S5B). An in silico study of the
-CASP family of MBL proteins has suggested that motif C
(Fig. 1C) is a histidine in RNA-processing enzymes such as
CPSF-73 but a valine in DNA-processing enzymes including
yeast Pso2 and human SNM1A, SNM1B, and SNM1C (42). To
test the proposed importance of this residue in determining
FIGURE 1. hSNM1A and hSNM1B hydrolysis of dsDNA is supported by a variety of divalent metal ion cofactors and inhibited bymetal ion chelators.
A, shown is a schematic representing the hSNM1A-catalyzed hydrolysis of cross-linked substrate described recently (14); hSNM1A, indicated in green, hydro-
lyzesDNA from the 5-end, pausing at the cross-linkedbase and then continuing todigestDNApast themodifiedbase, presumably leaving a single nucleotide
attached to the opposite strand via the cross-link. B, shown is alignment of the Pso2/Snm1 family, indicating the conservedMBL and-CASP domains in green
andorange, respectively. The canonicalMBLmotifs 1–4 are shown inblue, andmotifs A-Cof the-CASP family ofMBLs are shaded inpurple. Thegreenhatching
of the C-terminal part of the -CASP domain containing motifs B and C indicates the possibility suggested by structural studies that B and C form part of a
C-terminal extension of theMBL domain. C, shown is a model for the hSNM1A and hSNM1B active site arrangement based on the structure of human CPSF73
(43) and computational alignments (42). HumanSNM1A residues arenumbered inblue, andhSNM1B residues are in red,blue spheres indicate Zn2	 ions, the red
sphere represents bridging water, and arrows indicate possible hydrolytic mechanism. The conservedmotifs are shown in green. D–E, the extent of hydrolysis
in 30 min after the addition of wild-type hSNM1A (0.002 g; 4.1 nM) (D) or wild-type hSNM1B (0.02 g; 43.8 nM) (E) to 1000 nM 3 fluorescently labeled dsDNA
in the presence of 0.01, 0.1, 1, 5, or 10mMMgCl2 (lanes 1–5), 0.01, 0.1, 1, 5, or 10mMMnCl2 (lanes 6–10), 0.01, 0.1, 1, 5, or 10mM ZnCl2 (lanes 11–15), or 0.01, 0.1,
1, 5, or 10 mM CaCl2 (lanes 16–20). Lane UT, untreated sample of 3-fluorescein-containing 21-mer DNA. F and G, shown is the extent of hydrolysis in a 30-min
period after the addition of wild-type hSNM1A (0.007g; 14.3 nM) (F) or hSNM1B (0.045g; 98.6 nM) (G) to 1000 nM 3-labeled substrate in the presence of 10
mMMgCl2 and 0, 0.1, 1, 5, 10, or 25mM o-phenanthroline (lanes 1–6), 0, 0.1, 1, 5, 10, or 25mM EGTA (lanes 7–12), or 0, 0.1, 1, 5, 10, or 25mM EDTA (lanes 13–18).
H, hSNM1B (0.002g; 4.1 nM)was incubatedwith 1000 nM 3-fluorescently labeled dsDNA in the presence (lanes 12–20) or absence (lanes 2–10) of 1mMMgCl2.
Titrations of ZnCl2 were performed from 0 to 1mM in each case (lanes 2–10 and 11–20). Lane NE is samples of substrate DNAwhere no enzymewas added, and
either 0mM (lane 1) or 1mMMgCl2 was included (lane 11), respectively. For all panels, laneM indicates 3-labeledmarker oligonucleotides of the size indicated.
Reactions were carried out in a volume of 10 l, and gels are representative of multiple experiments, which show qualitatively similar results. nt, nucleotides.
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DNA/RNA substrate specificity, we made the V1016H change
in the context of hSNM1A (Fig. 1C). However, this substitution
had no effect on the DNA/RNA substrate preference (supple-
mental Fig. S5C), i.e. it did not increase relative preference for
RNA versus DNA and, therefore, a role for motif C in RNA
specificity is unlikely.
The pH Profile of the hSNM1A Protein Does Not Support the
Role of Conserved Histidine 994 as a General Acid Catalyst—In
a structural study of CPSF-73, an mRNA processing factor,
which is a member of the same protein family as hSNM1 fac-
tors, the co-crystallization of a sulfate ion as a structural mimic
of the scissile phosphate in the active site of the protein hinted
at a possible mechanism for phosphodiester bond hydrolysis
(see Fig. 1C). The study suggested that a hydroxide bridging two
zinc ions is well positioned for an in-line attack of the phos-
phate (sulfate) and that a histidine residue (residue 396 in
CPSF-73, residue 994 in hSNM1A) is a good candidate for act-
ing as a general acid catalyst (43). We tested this hypothesis by
comparing the pH profile of log(kcat) for wild-type hSNM1A
with that for the H994Amutant. No large shift in pH optimum
values was observed (compare supplemental Fig. S6, A with B),
and our data thus do not indicate a role for hSNM1A histidine
994 as a general acid catalyst. This discrepancy with the struc-
tural studymay be explained by the fact that themechanism for
leaving group stabilization could differ in the RNA- and DNA-
processing enzymes of the -CASP family of metallo--lacta-
mase type enzymes. This result highlights the need for further
structural studies of hSNM1A/B and other -CASPMBL fam-
ily members. However, it is also possible that another step is
rate-limiting the nuclease reaction such that changing the rate
of the leaving group departure has little effect on the actual
observed reaction rate. A recent study of yeast Pso2 biochemi-
cal activities proposes that the equivalent residue in Pso2, His-
611, is important for catalysis because its mutation abrogates
nucleolytic activities of Pso2 (51). This is interesting because, in
contrast, in our work we saw very little effect of the H994A
mutation on activity.
hSNM1A, but Not hSNM1B, Digests Higher Molecular
Weight DNA Substrates with Increased Efficiency—Because the
major physiological substrate of both hSNM1Aand hSNM1B is
FIGURE 2. hSNM1A and hSNM1B processivity in dsDNA and ssDNA hydrolysis and ability to digest DNA in the context of a plasmid substrate.
A, experiments were carried out in 10-l reaction volumes with 1 M substrate (3 fluorescently labeled dsDNA or ssDNA) and 0.006 g (12.3 nM) of hSNM1A
or 0.06g (131 nM) of hSNM1B containing dsDNAwith hSNM1A (lanes 1–3), ssDNAwith hSNM1A (lanes 4–6), dsDNAwith hSNM1B (lanes 7–9), and ssDNAwith
hSNM1B (lanes 10–12). Lane UT, untreated samples of 3-fluorescein-containing 21-mer DNA. Competition experiments were carried out as follows. The
reactionwaseither stoppedafter 5minby theadditionof 2l of stopbuffer andboiling (lanes 1,4,7, and10), the reactionhadexcessunlabeled substrate (16.67
M) added to it after 5min followed by stop buffer at 60min (lanes 2, 5, 8, 11), or the reactionwas stopped after 60min (lanes 3, 6, 9, 12). Gels are representative
of at least threedifferent experiments, and the same resultswere obtainedqualitativelywhen the timingof thedelay in addingunlabeled competitorDNAwas
varied. B and C, data from three independent experiments from Awere quantified for hSNM1A (B) and hSNM1B (C). nt, nucleotides.
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likely to be high molecular weight chromosomal DNA, in con-
trast to the oligonucleotide substrates used to date, we
addressed the issue of whether the exonucleolytic behavior of
the hSNM1 proteins is altered on high molecular weight sub-
strates. An excess of hSNM1B and hSNM1A was incubated
with an unmodified (circular), gapped or linearized plasmid, a
modified version of pUC18 (pUC18-shortgap4) illustrated in
supplemental Fig. S7C. Stimulation of the hSNM1B by gapped
or linearized plasmid was not observed for any version of this
plasmid substrate, as no significant digestion could be resolved
when the products were separated on relatively low resolution
agarose gels (Fig. 4A, compare lanes 2 and 8 and lane 3 with 9).
By contrast, gapped and linearized plasmid substrates were
hydrolyzed efficiently by hSNM1A (Fig. 4A, comparing lane 2
with 5, and lane 3 with 6) with an apparent digestion of at least
0.5 kb of plasmid substrate in 1 h; the reaction proceededmuch
farther than on oligonucleotide substrates in the same amount
of time (Fig. 4A, lane 6, compared with Fig. 2A, lane 3). To
address whether activity of hSNM1A becomesmore processive
on high molecular weight substrates, we digested gapped or
linearized plasmid in the presence of a large excess of unlabeled
double-stranded oligonucleotide substrate. Titrating in com-
petitor substrate to a hydrolysis by hSNM1Aof gapped (Fig. 4B,
lanes 1–9) or linearized (Fig. 4B, lanes 10–18) plasmid, we
found that a large excess (more than 25-fold) of competitor
dsDNAwas required to inhibit the hSNM1A reaction, suggest-
ing that the hydrolysis of higher molecular weight substrate
becomes processive.
A recent study proposed that one of the functions of yeast
Pso2 (51), aside from its role in interstrand cross-link repair,
may be the opening of hairpin substrates in analogy with the
hSNM1C/Artemis protein inmammals (28, 30, 52). To exclude
the possibility that the plasmid substrate was hydrolyzed by
hSNM1A endonucleolytically and in the light of this hairpin
opening activity proposed for yeast Pso2 protein, we used gel-
purified hairpin substrates blocked at the 5-end to confirm
that neither hSNM1A nor hSNM1B exhibit any endonuclease
activity (supplemental Fig. S7,A andB). Specifically, a fold-back
hairpin substrate with a 5-OHmoiety (supplemental Fig. S7,A
andB, lanes 1–6) or blockedwith a 5-biotin (supplemental Fig.
S7, A and B, lanes 7–12) was not degraded by an excess of
hSNM1A or hSNM1B within 120 min of enzyme addition, in
FIGURE 3. hSNM1A and hSNM1B multiple-turnover catalytic parameters for the hydrolysis of double-stranded or single-stranded 21-mer DNA
(dsDNA or ssDNA). Initial rates of reaction normalized to enzyme concentration (v/[E]) weremeasured in at least triplicate at substrate concentrations above
and below the Km values. The mean of v/[E] is shown, with error bars representing the standard error. Non-linear regression fitting was used to fit data to the
Michaelis-Menten equation (Equation 1) and generate the catalytic parameters and associated standard errors, as shown in the inset. The parameters were
measured at pH7.5 in reactionbuffer containing10mMMgCl2 for hSNM1A-catalyzedhydrolysis of dsDNA (A), hSNM1A-catalyzedhydrolysis of ssDNA (the inset
shows data between 0–100 nM substrate for clarity), hSNM1B-catalyzed hydrolysis of dsDNA (C), and hSNM1B-catalyzed hydrolysis of ssDNA (D). Substrate
concentrations ranged from 10 to 1200 nM (hSNM1A on dsDNA), 1.25–1200 nM (hSNM1A on ssDNA), 10–12,000 nM (hSNM1B on dsDNA), and 1.25–18,000 nM
(hSNM1B on ssDNA). In hSNM1B hydrolysis of ssDNA, it was not possible to reach saturation even at the highest substrate concentration (18,000 nM).
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contrast with a 5-phosphate containing hairpin, which was
degraded very efficiently (supplemental Fig. Fig. S7, A and B,
lanes 13–18). The same activity was observed using an alterna-
tive preparation of the enzymes overexpressed in insect cells,
and moreover, a 10-fold increase of enzyme concentration,
which led to complete hydrolysis of the 5-phosphate hairpin
within 5min, did not hydrolyze the 5-OHand 5-biotin hairpin
substrates (data not shown). Thus we conclude that neither
hSNM1A nor hSNM1B, at least in the absence of other pro-
teins, displays any hairpin opening activity.
Both hSNM1Aand hSNM1BDigest Past ICL Lesions in Vitro—
We recently demonstrated that hSNM1A is a nuclease with
ability to digest DNA past a site-specific cross-link (14). Given
that both hSNM1A and hSNM1B have been proposed to par-
FIGURE4.hSNM1AandhSNM1Barebothable tohydrolyzedsDNApast ablockage in thehydrolyzedaswell as in the complementary strand,butonly
hSNM1Ahydrolyzesplasmid-basedgappedand linearizedDNA,a reaction that isonly inhibitedby thepresenceofa largeexcess (more than25-fold)
of oligonucleotide substrate.A, hydrolysis of plasmid substrate, either intact, gapped, or linearized, by hSNM1Aor hSNM1B is shown. LaneM, GeneRuler 1kb
DNA ladder, plasmid substrate (pUC18-shortGAP46, 325ng; 16nM freeends) in theabsenceof enzyme (lanes 1–3), in thepresenceof 21nMhSNM1A (lanes 4–6),
or in the presence of 219 nM hSNM1B (lanes 7–9). Plasmid substrate was either left untreated (lanes 1, 4, and 7), gapped with NbBbvCI (lanes 2, 5, and 8), or
linearized with HindIII (lanes 3, 6, and 9). B, hydrolysis of plasmid substrate either gapped or linearized by hSNM1A in the presence of competitor dsDNA. Lane
M, GeneRuler 1-kb DNA ladder, plasmid substrate (pUC18-shortGAP46, 325 ng; 16 nM free ends) that has been gapped by NbBbvCI (lanes 1–9) or linearized by
HindIII (lanes 10–18) and treatedwith by 21nMhSNM1A in the presence of an increasing concentration of 21mer dsDNA.C, shownare time courses (0, 5, 30, 60,
120min) of hydrolysis of cross-linked substrate (lanes 1–10) and a non-cross-linked control (lanes 11–20) by 0.001g (2.0 nM) hSNM1A (lanes 1–5 and 11–15) or
0.195 g (427 nM) hSNM1B (lanes 6–10 and 16–20). nt, nucleotides.
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ticipate in ICL repair (14, 53, 54), possibly redundantly, we
investigated the relative activity of hSNM1A and hSNM1B on a
substrate containing an SJG-136 ICL lesion between the 5-ter-
minal guanosine and the complementary strand (0 nt, shown in
supplemental Table 1 and described in detail elsewhere (39)).
When such a substrate containing a 5-terminal ICLwas hydro-
lyzed in a time-dependent manner, both hSNM1A and
hSNM1Bwere able to hydrolyze past a cross-linked base on the
hydrolyzed strand within 30 min (Fig. 4C, lanes 3 and 8, for
hSNM1A and hSNM1B, respectively). However, an extended
time course (up to 120 min) suggested that hSNM1A may be
better at hydrolyzingDNApast a cross-linked base on the com-
plementary strand (Fig. 4C, compare lanes 4 and 5 with lanes 9
and 10). This result was consistently observed with multiple
batches of both enzymes, with a larger proportion of 11-mer
product visible after an extended time period in the hSNM1B
reaction as compared with the hSNM1A reactions.
Digestion by hSNM1A and hSNM1B of Fluorescein-contain-
ing DNA Enables the Development of a Real-time Assay for
Measuring Their Activity—Expanding on the result obtained
above, we assessed the ability of hSNM1A and hSNM1B to
digest substrates containing other bulky lesions, specifically
DNAblockedwith fluorescein, by the introduction of a fluores-
cein-dT phosphoramidite during the standard synthesis cycle
either in the digested (top) or complementary (bottom) strand.
Qualitatively, the data suggested that blocking the 5-terminus
of the dsDNA by the introduction of a dT-fluorescein base did
not affect the time course of the nuclease digestion catalyzed by
hSNM1A (Fig. 5A) or hSNM1B (Fig. 5B), as the extent of reac-
tion was similar with the top strand-modified substrate (Fig. 5,
A andB, lanes 1–6), the bottom strand-modified substrate (Fig.
5, A and B, lanes 7–12), and the unmodified substrate (Fig. 5, A
andB, lanes 12–18). In addition to the qualitative assessment of
the hSNM1A and hSNM1B activity on blocked substrates, we
measured the turnover rate for the removal of a 5 fluorescein-T
base and found this to be in the same range as the rate measured
withunmodifieddsDNA(datanot shown), indicating that thepro-
teins hydrolyzed lesion-containing substrates with a similar effi-
ciency as unmodified DNA.
Although the gel-based assay was useful in determining the
kinetic parameters and making basic comparisons between the
hSNM1A and hSNM1B proteins, it is not very quantitative and
is a relatively low throughput method. Recently, fluorescence
and fluorescence resonance energy transfer (FRET) based
assays have become prevalent in the assaying of a number of
biological systems, including nucleases (55, 56). Fluorescence-
based methods used to study nucleases involved in DNA
metabolism include, for example, an assay tomeasure the endo-
nuclease activity of archaeal XPF and Fen1 and the subsequent
analysis of substrate distortion as a result of protein binding (57,
FIGURE 5. hSNM1A and hSNM1B hydrolyze dsDNA past a fluorescein blockage, which enables the establishment of a real-time assay tomonitor the
reaction of hSNM1A (and hSNM1B). A and B, time courses (0, 2, 5, 10, 30, 60 min) of hSNM1A (A) or hSNM1B (B) catalyzed hydrolysis of dsDNA blocked with
abase-attached fluoresceinon the first nucleotideof the top strand (lanes 1–6), the first nucleotideof thebottomstrand (lanes 7–12), or not blockedat all (lanes
13–18). Lane M, 3-labeled marker oligonucleotides of the size indicated. Reactions were carried out in a volume of 10 l containing 1000 nM 3 radiolabeled
substrate and 0.01 g (20.4 nM) of hSNM1A or 0.1 g (219 nM) of hSNM1B. The gels shown are representative of multiple experiments and show qualitatively
similar results. C, D, and E, hSNM1A hydrolysis of fluorescein and BHQ1 double-labeled oligonucleotide, ds- or ssDNA, is accompanied by an increase in
fluorescence at 525 nm. C, shown is ds- and ssDNA substrate containing a fluorescein-T (green) and BHQ1-T (black) base. D, shown is an emission spectrum of
fluorescein before and after the addition of hSNM1A (excitation at 495 nm, 515 nm cut-off). E, shown is the time course of fluorescein emission at 525 nm
immediately after the addition of hSNM1A (excitation 495 nm, cut-off 515 nm) to 1000 nM ssDNA (open circles) or dsDNA (closed circles).
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58), a high throughput assay to identify inhibitors of human flap
endonuclease 1 (59), and a FRET-based way of identifying mul-
tiple modes of nucleolytic processing of DNA by lambda exo-
nuclease (60).
We aimed to design an assay that could measure hSNM1A
and hSNM1B activity in real time, exploiting the observation
that both proteinswere able to digestDNApast the bulky lesion
(Fig. 5, A and B). In analogy with the previous studies (57–59),
we tested the usefulness of a substrate with a 5-acceptor (Cy3)
and an internal donor (fluorescein) but saw no increase in
fluorescence because the exonuclease reaction was blocked by
the 5-modification of substrate (data not shown). However, we
were able to show that a real-time assay based on double label-
ing oligonucleotides internally with fluorescein and BHQ1
(black hole quencher) enabled us to measure the activity of
hSNM1A and hSNM1Bby following the increase in emission at
525 nm associated with the separation of fluorophore and
quencher molecules (Fig. 5, C–E). Using ssDNA, we revisited
the results obtained using the gel-based assay and confirmed
that for reactions carried out in the presence of a variety of
metal ion cofactors and inhibited by a range of metal chelators,
qualitatively similar results could be obtained (supplemental
Fig. S8). Thus, as a comparison of supplemental Fig. S8,A andB
with Fig. 1,D and E, shows, it is clear that the same dependence
of reactivity on magnesium or manganese concentration was
observed, with activity of hSNM1A and hSNM1B increasing
with increasing magnesium concentration (0.01–10 mM) and
manganese being a better cofactor for hSNM1B than hSNM1A.
Similarly, the hydrolysis rates measured in the presence of
o-phenanthroline, EGTA, or EDTA in the real-time assay (sup-
plemental Fig. S8,C andD) correspond to the extent of reaction
after 30 min in a single time point gel-based experiment (Fig. 1,
F and G, respectively). The reaction rate of wild-type and
H994A hSNM1A was also measured at varied pH using the
real-time assay, and the pattern observed and pKa values
obtained did not differ significantly from those measured in a
gel-based assay (compare supplemental Fig. S6, A and B with
supplemental Fig. S6, C and D, and values in the inset table).
This assay is potentially of great value in further directing
structure-function relationships of this family of nucleases
as well as identifying inhibitors in a high throughput screen-
ing effort.
DISCUSSION
Previous biochemical studies, including our own, of the
SNM1AandSNM1Bproteins have beenqualitative (23, 24) and
demonstrated that both proteins are 5-to-3 exonucleases that
require a terminal 5-phosphate for the digestion of ds- and
ssDNA. The yeast orthologue of the human SNM1 factors,
Pso2, has also been shown to have 5-exonuclease activity on
5-phosphate-containing ssDNA and dsDNA (23, 61) and, per-
haps surprisingly, an endonucleolytic activity on hairpin sub-
strates (51).
We have conducted a detailed kinetic analysis of the recom-
binant hSNM1A and hSNM1B proteins using both ds- and
ssDNA to ascertain their binding characteristics and catalytic
efficiency. We show that catalytic efficiency is comparable for
the two proteins (Fig. 3), which is about an order of magnitude
higher than the kcat values measured for yeast Pso2 recently
(51). This could be related to the relative protein solubility as it
has proven difficult to express and purify soluble full-length
Pso2 in large quantities (Refs. 23 and 61 and data not shown).
Although the catalytic efficiency of hSNM1A and hSNM1B is
similar, with short oligonucleotide substrates, hSNM1A binds
substrate more tightly than the related hSNM1B, as indicated
by a Km value in the nanomolar as compared with the micro-
molar range. The Km values measured indicated that hSNM1A
bound an ssDNA oligonucleotide substrate (21-mer) more effi-
ciently than dsDNA (compare Fig. 3, A and B). Conversely, the
Michaelis-Menten plot for hSNM1B hydrolysis of ssDNA (Fig.
3D) never reached saturation in the range of substrate concen-
trations studied (up to 18M), suggesting that hSNM1B bound
dsDNA more tightly albeit still much more weakly than
hSNM1A. The reactions were carried out with short oligonu-
cleotide substrates, raising the possibility that the activity of
these factors might be modified on high molecular weight sub-
strates more akin to genomic DNA. Using a gapped and linear-
ized plasmid substrate, we were unable to show a stimulation of
hSNM1B by high molecular weight DNA, whereas hSNM1A
efficiently degraded these substrates, digesting up to a kilobase
during the 60-min incubation. This suggests that the activity of
hSNM1A is altered upon incubation with such high molecular
weight DNA. Much higher levels of competitor were required
to inhibit the reaction of hSNM1A on high Mr DNA as com-
pared with oligonucleotide substrates (at least 25-fold fold as
comparedwith 5 fold), suggesting that hSNM1Abecomesmore
processive or much more active on high molecular weight
substrates.
In terms of the catalytic mechanism of SNM1A and SNM1B,
we built upon previous work regarding substrate specificity and
cofactor requirement. It was already known that the hSNM1A
exonuclease activity is dependent onmagnesium and is inactive
in excess zinc, EDTA, or iron(III) (24). We have shown that the
activity of both hSNM1A and hSNM1B is supported bymagne-
sium andmanganese and to a lesser extent by calcium (Fig. 1,D
and E); the hSNM1B activity was qualitatively higher in the
presence of manganese, whereas hSNM1A preferentially
cleaves DNA in the presence of magnesium, a result that was
consistently observed with multiple batches of the purified
enzymes. In agreement with a previous study (24), zinc at high
concentrationswas inhibitory to the reactions, but surprisingly,
we observed some hSNM1B activity in the presence of low
(below 0.02 mM) concentrations of added zinc. Because the
physiological metal ion cofactor of -CASP MBLs is still
unknown, an explanation for observation of activity at low but
not high zinc concentrationsmay be the need for a zinc cofactor
in one of the two active site metal ion sites and a second metal
such as magnesium in the other metal ion site where binding of
a second zinc ionmay be inhibitory as is the case for some, but
not all, metallo--lactamases. Indeed, further titration
experiments exploring the effect of titrating zinc in the pres-
ence of a fixed amount of magnesium (Fig. 1H) suggested
that two cation binding sites might be present and that occu-
pancy of zinc in one site is required for activity, but occupa-
tion of both sites by zinc is inhibitory. The need for zinc in
the active site may be further supported by the fact that
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activity of both hSNM1A and hSNM1B is more sensitive to
attenuation by o-phenanthroline, a zinc-selective chelator,
than by either EGTA or EDTA.
The role and identity ofmetal ions in the active site will in the
future be supported by structural studies, but the structural
data available on -CASP metallo--lactamases is still scarce.
One of the RNA-hydrolyzing members of the protein family,
CPSF-73, has been solved structurally in the presence of a sul-
fate ion mimicking a scissile phosphate (43), and the authors
propose a general acid catalysis mechanism involving a histi-
dine residue.We substituted the equivalent histidine residue in
hSNM1A to test its role but foundnobiochemical evidence that
the residue acts as a general catalyst in hSNM1A (supplemental
Fig. S6). Although the sulfate ion may have cocrystallized with
CPSF-73 in a location distinct from the scissile phosphate bind-
ing pocket, such as in the 5-phosphate binding pocket, the
mechanism suggested by the structural study remains an
attractive one due to the position of the two metal ions, appar-
ently well located to deprotonate an attacking water nucleo-
phile. As implied elsewhere with relation to Artemis (42), a
possible explanation for the discrepancy is that the nucleolytic
mechanism differs between RNA- and DNA-processing
enzymes because of the differing intrinsic stabilities of the scis-
sile phosphate. However, it is of note that a very recent publi-
cation discussing the biochemical activities of Pso2, the yeast
homologue of hSNM1A, suggested that mutation of the equiv-
alent histidine in yeast Pso2 (histidine 611) abolishes its
nuclease activity completely (51), which contrasts with our data
that suggest that the hSNM1A H994A mutant protein exhibits
near wild-type activity (supplemental Fig. S6). Intriguingly also,
the Pso2 biochemistry study suggested a hairpin opening endo-
nucleolytic activity for Pso2 (51), in contrast with hSNM1A,
where such activity has not been observed (Ref. 24 and data not
shown). We confirmed that neither hSNM1A nor hSNM1B, at
least in the absence of other protein cofactors, shows hairpin
opening endonuclease activity (supplemental Fig. S7, A and B).
It is thus possible that both functional and mechanistic differ-
ences between the hSNM1A and Pso2 proteins may become
apparent, particularly because in yeast, Pso2 is the only factor of
this protein family so far identified, whereas human cells con-
tain three homologues, hSNM1A, hSNM1B/Apollo, and
hSNM1C/Artemis.
Taking advantage of the near-normal hydrolysis activity of
both SNM1Aand SNM1BonDNAcontaining fluoresceinmoi-
eties, we were able to develop a higher throughput assay to
replace the gel-based method of kinetic parameter measure-
ment. Using the assay to assess metal ion dependence and inhi-
bition by metal chelators, we obtained results that were quali-
tatively similar to those obtained in a gel-based assay, and the
pH profiles of wild-type and H994A hSNM1A hydrolysis were
similar whether measured in a gel-based or real-time fluores-
cence based assay. The higher throughput nature of the real-
time assay compared with a gel-based system clearly opens up
the possibility for advanced mechanistic studies of the SNM1
family of proteins, and after optimization and scaling of the
assay, our study provides a good starting point for this process.
In addition to being a rapid platform to further characterize
SNM1-family biochemical characteristics, the real-time assay
can be used in screens for small molecule inhibitors. This is of
relevance particularly because the development of small mole-
cule inhibitors of the human SNM1-family proteins might sug-
gest new strategies to therapeutically sensitize tumors to ICL-
inducing agents as well as providing valuable research reagents.
Importantly, due to the similarity of the hSNM1A active site
and bacterial MBLs (43, 62, 63), candidate MBL inhibitors are
already available and may be a good starting point for identify-
ing potential hSNM1A and hSNM1B inhibitors.
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